Connie Cooper

Published 19th Jan 2026 The approval was granted based on data from the phase three, randomised, double-blind, placebo-controlled trial.

Published 16th Jan 2026 To kick off the new year year, we've compiled.a list of the latest advanced beauty launches of 2026. Skynverse - price on request Skynreverse is a new medical-grade fractional laser, clinically proven to dramatically reverse the signs of aging using a combination of erbium and thulium wavelengths for deep dermal remodelling and superficial resurfacing.

Updated on 12th Jan 2026 The US Food and Drug Administration (FDA) has approved Novo Nordisk’s pill Wegovy, which is now available in US pharmacies. Clinical trials showed that patients achieved similar weight loss with the oral medication as with the injectable GLP-1 drug Wegovy. In a 64-week phase 3 clinical trial, the Wegovy pills demonstrated a mean weight loss of 16.6%, with a third of the 1,300 participants experiencing a weight loss of 20% or greater.